Department of Women and Children's Health, Uppsala University, Uppsala, Sweden.
Acta Oncol. 2013 May;52(4):753-8. doi: 10.3109/0284186X.2012.716163. Epub 2012 Aug 31.
Intracranial haemangiopericytoma (HPC), a rare malignant tumour, should be distinguished from meningioma and solitary fibrous tumour, which have been considered as separate entities since 1993, according to histopathology and clinical characteristics.
A PUBMED search for "Intracranial Haemangiopericytoma" yielded 176 articles, where 26 were of particular interest for this review article.
Our patient, a 27-year-old man with HPC of grade III according to WHO, presents with an acute intracerebral haematoma, which is extremely rare.
Surgery (total resection) is the primary treatment. Long-term close clinical and radiological follow-up is crucial due to the high rate of recurrence and tendency for development of metastasis.
The effects of postoperative radiotherapy need further investigation. Besides neurosurgery, radiotherapy should always be considered in both patients with these highly malignant tumours (WHO grade III) and in patients with partial resection or inoperable cases (WHO grade II).
颅内血管外皮细胞瘤(HPC)是一种罕见的恶性肿瘤,根据组织病理学和临床特征,应与脑膜瘤和孤立性纤维瘤区分开来,自 1993 年以来,这两种肿瘤已被视为独立实体。
在 PUBMED 上搜索“颅内血管外皮细胞瘤”,共得到 176 篇文章,其中 26 篇对本文综述特别有意义。
我们的患者是一名 27 岁男性,根据世卫组织分级为 III 级 HPC,表现为急性颅内血肿,这极为罕见。
手术(完全切除)是主要治疗方法。由于高复发率和转移倾向,长期密切的临床和影像学随访至关重要。
术后放疗的效果需要进一步研究。除神经外科外,对于这些高度恶性肿瘤(世卫组织分级 III 级)的患者,以及对于部分切除或不可切除的患者(世卫组织分级 II 级),放疗也应始终考虑。